Home / PDA Letters (Cards)

PDA Letters (Cards)

Regulator Develops Remote Inspection Process Due to Pandemic

Vladislav Shestakov, Russian State Institute of Drugs and Good Practices, and Elizabeth Meyers, Amgen

PDA Honor Awards: Distinguished Service Awards

Rebecca Stauffer, PDA

PDA Honor Awards: Service Appreciation Awards Part II

Rebecca Stauffer, PDA

States Temporarily Relax EtO Restrictions

Rebecca Stauffer, PDA

PDA and PDA Letter Plow Ahead

Rebecca Stauffer, PDA

10 Practical Tips for Crisis Management in Pharma Manufacturing

Satya Moturi, PhD, Biological E. Ltd

PDA Honor Awards: Service Appreciation Awards Part I

Rebecca Stauffer, PDA

A Virtual Look at Risk Management for Prefilled Syringes

Anthony Grilli, Focus Laboratories, and PDA Metro Chapter President

Closed System Transfer Devices Prove Hot PDA Topic

Bettine Boltres, PhD, West Pharmaceutical Services, Inc.

CEO Showcases Future of CGT Therapies for PDA Chapter

PDA Capital Area Chapter

3 Approaches to Viral Safety

Thomas R. Kreil, Takeda

Container Closure Integrity Testing with Lauren Lavec

PDA Letter editors

4 Ways to Manage Your Supply Chain and Mitigate Drug Shortages

Dawn MacNeill, MilliporeSigma

Dinner Meeting Addresses Virtual Companies, Preapproval Inspections

Sunil Anklekar, PhD, Lantheus Medical Imaging, and Treasurer, PDA New England Chapter, and Jacklyn Chesny

Visual Inspection Practices of Cleaned Equipment: Part II

Walid El Azab, STERIS, and Stephane Cousin, GSK

Guest Editorial: A Litmus Test for a Culture of Quality

John D. Ayres, MD, Pharma Safety Solutions, LLC

Chapter Covers New Developments in Visual Inspection

Aidan Harrington, Senior Consultant DPS Global, and President-Elect, PDA Ireland Chapter

PDA Comments Address Risk Management Approach to Gene Therapy CMC

Rebecca Stauffer, PDA

New Vial Technology Shows Promise for Manufacturing Productivity

Dawn Watson and Jeff Cremi, Merck & Co., Inc.

PDA Board of Directors Changes

Rebecca Stauffer, PDA